View Comments
In the first reported case of its kind, a healthy 85-year-old man developed a rare recurrence of deep-vein blood clots in his upper arm as the result of coronavirus infection, Rutgers researchers report.
The unusual case highlights yet another way the virus that causes COVID-19 can affect people. Beyond the more common respiratory symptoms and loss of taste and smell, the virus can trigger coagulation disorders, especially clots.
“This is of concern, since in 30% of these patients, the blood clot can travel to the lung and be possibly fatal,” said Dr. Payal Parikh, an assistant professor of medicine at Rutgers Robert Wood Johnson Medical School, who led the study along with Martin Blaser, director of the Center for Advanced Biotechnology and Medicine. “Other disabling complications include persistent swelling, pain and arm fatigue.”
COVID symptoms: Blood clots could be another complication
app.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from app.com Daily Mail and Mail on Sunday newspapers.
COVID symptoms: Blood clots could be another complication
mycentraljersey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from mycentraljersey.com Daily Mail and Mail on Sunday newspapers.
Evelo Biosciences, Inc. (EVLO) Q1 2021 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble.
Evelo Biosciences, Inc. (NASDAQ: EVLO)
Q1 2021 Earnings Call
Good morning, and welcome to Evelo Biosciences conference call to discuss the first-quarter 2021 financial results and business highlights. [Operator instructions] Please be advised that this call is being recorded at the company s request. At this time, I d like to turn the call over to Jessica Cotrone of Evelo. Please proceed.
Jessica Cotrone
Vice President, Head of of Communications
Thank you. This morning we issued the press release that outlines the topics we plan to discuss today. This release is available at www.evelobio.com under the investors tab. Today in our call, we have Simba Gill, chief executive officer; Mark Bodmer, president of R&D and chief scientific officer; and Jonathan Zung, chief development officer.